New: Introducing the Finviz Crypto Map

Learn More
Last Close
Jul 18 04:00PM ET
24.99
Dollar change
-0.40
Percentage change
-1.58
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y- Total Holdings35 Perf Week-0.39%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- AUM59.57M Perf Month0.12%
Fund Family Bond Type Tagsinnovation Return% 5Y- NAV/sh Perf Quarter5.19%
Index- Average Maturity Tagshealthcare Return% 10Y 52W High27.76 -10.00% Perf Half Y5.53%
Index Weighting Commodity Type Tagsbiotechnology Return% SI 52W Low18.78 33.04% Perf YTD6.82%
Active/Passive Quant Type Tagsmedical Flows% 1M4.82% Volatility0.33% 0.69% Perf Year-
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M5.62% ATR (14)0.37 Perf 3Y-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD12.26% RSI (14)55.45 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta- Perf 10Y-
Expense0.54% Growth/Value SMA200.78% Flows% 3Y Rel Volume3.93 Prev Close25.39
Inverse/Leveraged Market Cap SMA505.85% Flows% 5Y Avg Volume2.56K Price24.99
IPOOct 31, 2024 Option/ShortNo / Yes SMA2003.20% Trades Volume10,061 Change-1.58%
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.